Cite
HARVARD Citation
Mariotti, J. et al. (2018). Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma. Bone marrow transplantation. pp. 366-370. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mariotti, J. et al. (2018). Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma. Bone marrow transplantation. pp. 366-370. [Online].